clarithromycin has been researched along with interleukin-8 in 54 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (18.52) | 18.2507 |
| 2000's | 31 (57.41) | 29.6817 |
| 2010's | 11 (20.37) | 24.3611 |
| 2020's | 2 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyagi, T; Eguchi, K; Kawabe, Y; Kawakami, A; Matsuoka, N; Nagataki, S; Tsuboi, M | 1 |
| Ikemura, N; Imoto, I; Misaki, M; Nakao, K; Shibata, T; Taguchi, Y; Takaji, S; Yamauchi, K; Yamazaki, N | 1 |
| Furukawa, M; Ikeda, K; Shimomura, A; Suzuki, H; Takasaka, T; Wataya, H | 1 |
| Abe, S; Nakamura, H; Takeda, H; Tomoike, H | 1 |
| Abe, S; Kato, S; Nakamura, H; Takeda, H; Tomoike, H | 1 |
| Fujita, K; Majima, Y; Sakakura, Y; Shimizu, T; Usui, T | 1 |
| Ito, K; Kawasaki, S; Koyama, T; Otoshi, T; Takami, K; Takizawa, H | 1 |
| Matsushima, K; Nagatake, T; Oishi, K; Omura, T; Yoshimine, H | 1 |
| Desaki, M; Obata, R; Omura, S; Otoguro, K; Sunazuka, T; Suzuki, K; Takizawa, H | 1 |
| Akiyama, N; Ito, K; Kawasaki, S; Kohyama, T; Sato, M; Takizawa, H | 1 |
| Abe, S; Inoue, S; Kato, S; Matsushima, K; Mukaida, N; Nakamura, H; Saito, H; Takeda, H; Tomoike, H | 1 |
| Kadoyama, J; Katayama, I; Matsunaga, Y | 1 |
| Abisheganaden, JA; Avila, PC; Boushey, HA; Kishiyama, JL; Liu, J; Schnurr, D; Yagi, S | 1 |
| Fujita, K; Majima, Y; Sakakura, Y; Shimizu, T | 1 |
| Griffith, DE; Kurdowska, A; Noble, JM | 1 |
| Boushey, HA; Grundland, H; Liu, JT; Ordoñez, CL; Stulbarg, M | 1 |
| Katayama, I; Matsunaga, Y; Monden, J | 1 |
| Komiya, N; Tamaoki, K | 1 |
| Enomoto, F; Fujimori, M; Ichikawa, G; Kim, R; Okazoe, S | 1 |
| Gomi, K; Hagiwara, K; Honda, Y; Kikuchi, T; Kobayashi, T; Nukiwa, T; Takahashi, H; Tokue, Y; Watanabe, A | 1 |
| Andou, I; Enomoto, F; Ichikawa, G; Nagaoka, I | 1 |
| Cervin, A; Coman, W; Feron, F; Mackay-Sim, A; Wallwork, B | 1 |
| Bancel, B; Corthesy-Theulaz, I; Crabtree, JE; Diezi, J; Felley, CP; Felley-Bosco, E; Michetti, P; Ohshima, H; Patricot, LM; Pignatelli, B; Stolte, M; Van Melle, GD | 1 |
| Abe, S; Inoue, S; Nakamura, H; Otake, K; Sada, M; Takeda, H | 1 |
| Berg, HF; Kluytmans, JA; Maraha, B; Peeters, MF; Scheffer, GJ | 1 |
| Arrieta, A; Gonzalez, G; Scharer, G; Singh, J; Vargas-Shiraishi, O; Zaldivar, F | 1 |
| Aiba, Y; Koga, Y; Mine, T; Shiba, T; Takagi, A; Tanaka, K; Ushiyama, A | 1 |
| Deguchi, K; Kurono, Y; Matsune, S; Nishimoto, K; Takaki, M; Ushikai, M | 1 |
| Hagiwara, K; Honda, Y; Kikuchi, T; Nukiwa, T; Watanabe, A | 1 |
| Basyigit, I; Boyaci, H; Ilgazli, A; Ozkara, SK; Yildirim, E; Yildiz, F | 1 |
| Hahm, JS; Han, DS; Jang, MK; Kim, HY; Kim, KH; Lee, JH; Lee, JY; Park, JY; Yoo, JY | 1 |
| Foster, GH; Rubin, BK; Shinkai, M | 1 |
| Cho, YS; Kim, SS; Konkin, TA; Meitner, P; Moss, SF; Resnick, MB | 1 |
| Jang, YJ; Kwon, HJ; Lee, BJ | 1 |
| Ariyürek, M; Doğru, D; Firat, P; Göçmen, A; Gürcan, N; Kiper, N; Mocan, G; Ozçelik, U; Sahin, A; Yalçin, E | 1 |
| Koc, N; Ozcan, A; Tahan, F | 1 |
| Abe, Y; Harabuchi, Y; Ishida, Y | 1 |
| López-Boado, YS; Rubin, BK; Shinkai, M | 1 |
| Boyle, MJ; Gibson, PG; Powell, H; Scott, RJ; Simpson, JL | 1 |
| Hayashi, Y; Ishikawa, C; Konishi, H; Matsuki, M; Mizutani, H; Nakagawa, N; Tsuda, T; Yamanishi, K | 1 |
| Fujita, H; Hara, A; Hara, S; Ishimatsu, Y; Kakugawa, T; Kohno, S; Mukae, H; Sakamoto, N | 1 |
| Itakura, S; Kamiya, S; Kouyama, T; Nagase, T; Omura, S; Sunazuka, T; Takizawa, H; Yamauchi, Y | 1 |
| Chang, CS; Ho, SP; Huang, LR; Peng, YC; Shyu, CL | 1 |
| Bonella, F; Cai, M; Costabel, U; Dai, H; Guzman, J; Sarria, R | 1 |
| Ding, M; Fan, Y; Hong, H; Li, H; Luo, Q; Lv, M; Shi, J; Xia, W; Xu, R | 1 |
| Matsubara, S; Mikamo, H; Yamagishi, Y | 1 |
| Colombo, G; Haghi, M; King, G; Saadat, A; Traini, D; Young, PM; Zhu, B | 1 |
| Chorostowska-Wynimko, J; Gawryluk, D; Jaguś, P; Radzikowska, E; Roszkowski-Śliż, K; Roży, A; Wiatr, E | 1 |
| Hayase, N; Iwayama, K; Kusakabe, A; Nawano, T; Ohtaki, KI; Ohtsu, K; Tampo, Y; Tatsunami, R | 1 |
| Antonakos, N; Bauer, M; Giamarellos-Bourboulis, EJ; Lada, M; Machairas, N; Oberle, V; Pistiki, A; Souli, M; Tsaganos, T; Tsangaris, I | 1 |
| Arakawa, K; Deng, X; Kawase, T; Lusamba Kalonji, N; Nagatomi, R; Nishimura, H; Nomura, K; Sugawara, M; Yamada, M; Yamaya, M | 1 |
| Bergamini, G; Boaretti, M; Boschi, F; Cremonini, E; Lleo, M; Melotti, P; Ortombina, A; Sandri, A; Sorio, C | 1 |
| Ishida, M; Matsune, S; Okubo, K; Ōmura, S; Sekine, K; Sunazuka, T; Takahara, E; Wakayama, N; Yamaguchi, S; Yoshioka, Y | 1 |
| Li, W; Li, X; Ma, R; Ren, Z; Yan, A; Zhao, N | 1 |
1 review(s) available for clarithromycin and interleukin-8
| Article | Year |
|---|---|
[Infection and host reaction].
Topics: Animals; Clarithromycin; Humans; Immunity, Innate; Infections; Interleukin-8; Neutrophils | 2013 |
10 trial(s) available for clarithromycin and interleukin-8
| Article | Year |
|---|---|
Effect of clarithromycin on experimental rhinovirus-16 colds: a randomized, double-blind, controlled trial.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Common Cold; Double-Blind Method; Female; Humans; Inflammation; Interleukin-6; Interleukin-8; Leukocyte Count; Male; Nasal Lavage Fluid; Neutrophils; Prospective Studies; Rhinovirus; Severity of Illness Index; Trimethoprim, Sulfamethoxazole Drug Combination | 2000 |
[Therapeutic effects of macrolides on patients with palmoplantar pustulosis].
Topics: Adult; Aged; Anti-Bacterial Agents; Cells, Cultured; Clarithromycin; Cytokines; Erythromycin; Female; Humans; Interleukin-8; Keratinocytes; Male; Middle Aged; Psoriasis; Treatment Outcome | 2001 |
Oxidative stress in gastric mucosa of asymptomatic humans infected with Helicobacter pylori: effect of bacterial eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biomarkers; Biopsy; Catalase; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-8; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Omeprazole; Oxidative Stress; Superoxide Dismutase | 2002 |
Effect of clarithromycin on inflammatory markers in patients with atherosclerosis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; C-Reactive Protein; Clarithromycin; Coronary Artery Bypass; Coronary Artery Disease; Double-Blind Method; Female; Humans; Inflammation; Interleukin-6; Interleukin-8; Male; Middle Aged; Prospective Studies; Receptors, Interleukin-2; Treatment Failure; Tumor Necrosis Factor-alpha | 2003 |
The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Biomarkers; Clarithromycin; Double-Blind Method; Humans; Inflammation Mediators; Interleukin-8; Leukotriene B4; Male; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Sputum; Tumor Necrosis Factor-alpha | 2004 |
Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis.
Topics: Adolescent; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bronchiectasis; Bronchoalveolar Lavage Fluid; Child; Clarithromycin; Colony Count, Microbial; Female; Humans; Interleukin-10; Interleukin-8; Leukocyte Count; Male; Respiratory Function Tests; Sputum; Tumor Necrosis Factor-alpha | 2006 |
Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial.
Topics: Anti-Bacterial Agents; Bronchiolitis, Viral; Chemokine CCL11; Chemokines, CC; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Female; Humans; Infant; Interferon-gamma; Interleukin-4; Interleukin-8; Length of Stay; Male; Respiratory Syncytial Virus Infections | 2007 |
Clarithromycin targets neutrophilic airway inflammation in refractory asthma.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asthma; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gene Expression; Humans; Interleukin-8; Leukocyte Count; Male; Middle Aged; Neutrophils; Quality of Life; Sputum | 2008 |
High and low doses of clarithromycin treatment are associated with different clinical efficacies and immunomodulatory properties in chronic rhinosinusitis.
Topics: Adult; Anti-Bacterial Agents; Biomarkers; Chronic Disease; Clarithromycin; Dose-Response Relationship, Drug; Female; Humans; Interleukin-5; Interleukin-8; Male; Middle Aged; Quality of Life; Rhinitis; Sinusitis; Surveys and Questionnaires; Treatment Outcome | 2014 |
Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome.
Topics: Aged; Aged, 80 and over; Clarithromycin; Decision Support Techniques; Female; Gram-Negative Bacteria; Granulocyte-Macrophage Colony-Stimulating Factor; Greece; Humans; Infections; Interferon-gamma; Interleukin-10; Interleukin-6; Interleukin-8; Leukocytes, Mononuclear; Logistic Models; Male; Middle Aged; Placebos; Prospective Studies; Recombinant Proteins; ROC Curve; Statistics, Nonparametric; Survivors; Tumor Necrosis Factor-alpha | 2017 |
43 other study(ies) available for clarithromycin and interleukin-8
| Article | Year |
|---|---|
Inhibitory effect of clarithromycin on costimulatory molecule expression and cytokine production by synovial fibroblast-like cells.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antigens, CD; Arthritis, Rheumatoid; B7-1 Antigen; CD58 Antigens; Cell Adhesion Molecules; Cells, Cultured; Clarithromycin; Cytokines; Dose-Response Relationship, Drug; Fibroblasts; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; HLA-DR Antigens; Humans; Immunoenzyme Techniques; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-1; Interleukin-10; Interleukin-6; Interleukin-8; Lymphocyte Activation; Osteoarthritis; Synovial Membrane; T-Lymphocytes; Tetradecanoylphorbol Acetate; Tuberculin; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 1996 |
Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ammonia; Anti-Bacterial Agents; Anti-Ulcer Agents; Biomarkers; Biopsy; Chronic Disease; Clarithromycin; Duodenal Ulcer; Female; Follow-Up Studies; Gastric Juice; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-8; Lactoferrin; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pyloric Antrum | 1997 |
[Il-8 secretion by cultured epithelial cells of human nasal mucosa and its suppression by macrolide antibiotics].
Topics: Administration, Topical; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cells, Cultured; Clarithromycin; Dexamethasone; Epithelial Cells; Erythromycin; Glucocorticoids; Humans; Interleukin-8; Josamycin; Nasal Mucosa; Roxithromycin | 1997 |
[Macrolide antibiotic actions on bacteria and cultured airway cells].
Topics: Anti-Bacterial Agents; Cells, Cultured; Clarithromycin; Epithelial Cells; Humans; Interleukin-8; Miocamycin; Pseudomonas aeruginosa; Respiratory System | 1997 |
[Effect of macrolides on IL-8 gene expression by cultured airway epithelial cells].
Topics: Anti-Bacterial Agents; Bronchi; Cells, Cultured; Clarithromycin; Erythromycin; Gene Expression; Humans; Interleukin-8; RNA, Messenger | 1998 |
[Neutrophil count and IL-8 level of nasal secretion of patients with chronic paranasal sinusitis and the effects of macrolide antibiotics].
Topics: Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Female; Humans; Interleukin-8; Leukocyte Count; Male; Middle Aged; Nasal Mucosa; Neutrophils; Sinusitis | 1998 |
[Effects of various drugs on IL-8 production by eosinophils collected from patients with allergic inflammation].
Topics: Anti-Bacterial Agents; Asthma; Clarithromycin; Eosinophils; Erythromycin; Fosfomycin; Humans; Hypersensitivity; Immunosuppressive Agents; In Vitro Techniques; Interleukin-8; Josamycin; Tacrolimus | 1998 |
[Inhibition of neutrophil-derived IL-8 production caused by EM (erythromycin) 201 derivative: modification of the activities by the 5-position desosamine side chain].
Topics: Anti-Bacterial Agents; Cells, Cultured; Clarithromycin; Erythromycin; Humans; Interleukin-8; Neutrophils; Structure-Activity Relationship | 1998 |
Effects of erythromycin and its derivatives on interleukin-8 release by human bronchial epithelial cell line BEAS-2B cells.
Topics: Anti-Bacterial Agents; Bronchi; Cell Line; Clarithromycin; Colony Count, Microbial; Epithelial Cells; Erythromycin; Gastrointestinal Motility; Humans; Interleukin-8; Stimulation, Chemical; Structure-Activity Relationship | 1999 |
Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors.
Topics: Anti-Bacterial Agents; Clarithromycin; Eosinophils; Erythromycin; Humans; Immunohistochemistry; Interleukin-8; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 1999 |
Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells.
Topics: 5' Untranslated Regions; Binding Sites; Bronchi; Cell Division; Cells, Cultured; Clarithromycin; Epithelial Cells; Gene Expression Regulation; Genes, Reporter; Humans; Interleukin-8; Luciferases; Promoter Regions, Genetic; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2000 |
[Effect of clarithromycin on KL-8 formation by epidermal keratocytes].
Topics: Anti-Bacterial Agents; Cells, Cultured; Clarithromycin; Epidermal Cells; Humans; Immunologic Factors; Interleukin-8; Keratinocytes | 2000 |
Effects of macrolides on interleukin-8 secretion from human nasal epithelial cells.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cells, Cultured; Child; Chronic Disease; Clarithromycin; Drug Administration Schedule; Epithelium; Erythromycin; Humans; Interleukin-1; Interleukin-8; Middle Aged; Nasal Mucosa; Neutrophils; Nose; Sinusitis | 2000 |
The effect of azithromycin and clarithromycin on ex vivo interleukin-8 (IL-8) release from whole blood and IL-8 production by human alveolar macrophages.
Topics: Analysis of Variance; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Humans; Interleukin-8; Leukocytes, Mononuclear; Macrophages, Alveolar | 2001 |
Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study.
Topics: Adult; Airway Obstruction; Anti-Bacterial Agents; Biomarkers; Clarithromycin; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Inflammation; Interleukin-8; Leukocyte Elastase; Male; Neutrophils; Peroxidase; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Respiratory Function Tests; Single-Blind Method; Sputum; Treatment Outcome; Tumor Necrosis Factor-alpha | 2001 |
[Calcium dependent effect of clarithromycin on IL-8 production in cultured human epidermal cells].
Topics: Anti-Bacterial Agents; Calcium; Cells, Cultured; Clarithromycin; Depression, Chemical; Dose-Response Relationship, Drug; Epidermal Cells; Humans; Interleukin-8; Keratinocytes | 2001 |
[Effects of macrolides on cultured rat vascular cells].
Topics: Animals; Anti-Bacterial Agents; Cell Adhesion; Cells, Cultured; Clarithromycin; Endothelium, Vascular; Erythromycin; Intercellular Adhesion Molecule-1; Interleukin-8; Neutrophil Infiltration; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2001 |
Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappa B transcription factors.
Topics: Anti-Bacterial Agents; Clarithromycin; Depression, Chemical; Escherichia coli; Humans; Indicators and Reagents; Interleukin-8; Leukemia, Monocytic, Acute; Lipopolysaccharides; Luciferases; Monocytes; NF-kappa B; Nuclear Proteins; Pancreatitis-Associated Proteins; Plasmids; RNA, Messenger; Transcription Factor AP-1; Transfection; Tumor Cells, Cultured | 2002 |
Effect of new macrolides on the expression of adhesion molecules on neutrophils in chronic sinusitis.
Topics: Adolescent; Adult; Aged; Chronic Disease; Clarithromycin; Down-Regulation; Female; Humans; Interleukin-8; L-Selectin; Macrophage-1 Antigen; Male; Middle Aged; Neutrophils; Roxithromycin; Sinusitis; Up-Regulation | 2002 |
Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Chronic Disease; Clarithromycin; Culture Techniques; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Glucocorticoids; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-5; Interleukin-8; Male; Middle Aged; Nasal Mucosa; Prednisolone; Rhinitis; Sinusitis | 2002 |
[Effects of 14-, 15-, and 16-membered ring macrolides on IL-8 gene expression in BET-1A cells].
Topics: Anti-Bacterial Agents; Azithromycin; Bronchi; Cells, Cultured; Clarithromycin; Depression, Chemical; Epithelial Cells; Erythromycin; Gene Expression; Humans; Inflammation Mediators; Interleukin-8; Miocamycin; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2001 |
Systemic inflammatory responses in children with acute otitis media due to Streptococcus pneumoniae and the impact of treatment with clarithromycin.
Topics: Biomarkers; Case-Control Studies; Child, Preschool; Clarithromycin; Follow-Up Studies; Humans; Infant; Inflammation; Interleukin-1; Interleukin-6; Interleukin-8; Interleukins; Otitis Media with Effusion; Pilot Projects; Pneumococcal Infections; Time Factors; Tumor Necrosis Factor-alpha | 2003 |
Lactobacillus gasseri OLL2716 as a probiotic in clarithromycin-resistant Helicobacter pylori infection.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Interleukin-8; Lactobacillus; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Probiotics | 2003 |
The role of nuclear factor-kappa B in interleukin-8 expression by human adenoidal fibroblasts.
Topics: Adenoids; Clarithromycin; Electrophoretic Mobility Shift Assay; Endotoxins; Fibroblasts; Haemophilus influenzae; Humans; Interleukin-1; Interleukin-8; NF-kappa B; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tosylphenylalanyl Chloromethyl Ketone; Transcriptional Activation | 2003 |
[Suppressive mechanism of clarithromycin on lipopolysaccharide-induced IL-8 production in human monocytes by mediating AP-1 and NF-kappaB].
Topics: Anti-Bacterial Agents; Cells, Cultured; Clarithromycin; Depression, Chemical; Gene Expression Regulation; Humans; Interleukin-8; Lipopolysaccharides; Monocytes; NF-kappa B; Promoter Regions, Genetic; Transcription Factor AP-1 | 2003 |
Macrolide-affected Toll-like receptor 4 expression from Helicobacter pylori-infected monocytes does not modify interleukin-8 production.
Topics: Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-8; Lipopolysaccharides; Macrolides; Membrane Glycoproteins; Monocytes; Receptors, Cell Surface; Toll-Like Receptor 4; Toll-Like Receptors | 2005 |
Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells.
Topics: Anti-Bacterial Agents; Azithromycin; Bronchi; Cells, Cultured; Clarithromycin; Dexamethasone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Imidazoles; Interleukin-8; Lipopolysaccharides; Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Reference Values; Threonine; Time Factors; Tyrosine | 2006 |
Altered expression of Skp2, c-Myc and p27 proteins but not mRNA after H. pylori eradication in chronic gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Cyclin-Dependent Kinase Inhibitor p27; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Interleukin-8; Lansoprazole; Male; Middle Aged; Omeprazole; Proteins; Proto-Oncogene Proteins c-myc; Proton Pump Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; S-Phase Kinase-Associated Proteins | 2006 |
Effect of clarithromycin on rhinovirus-16 infection in A549 cells.
Topics: Cells, Cultured; Clarithromycin; Cytokines; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Humans; Intercellular Adhesion Molecule-1; Interleukin-1; Interleukin-6; Interleukin-8; Lung; Picornaviridae Infections; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Rhinovirus; RNA, Messenger; Up-Regulation; Virus Replication | 2006 |
Effects of macrolides on antigen presentation and cytokine production by dendritic cells and T lymphocytes.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antigen Presentation; Bacterial Outer Membrane Proteins; CD4-Positive T-Lymphocytes; Cell Proliferation; Cells, Cultured; Clarithromycin; Cytokines; Dendritic Cells; Haemophilus influenzae; Haemophilus Vaccines; Humans; Interleukin-8; Interleukins; Macrolides; Prednisolone; Roxithromycin | 2007 |
Clarithromycin has an immunomodulatory effect on ERK-mediated inflammation induced by Pseudomonas aeruginosa flagellin.
Topics: Alginates; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clarithromycin; Dexamethasone; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Flagellin; Immunologic Factors; Indicators and Reagents; Inflammation; Interleukin-8; Lipopolysaccharides; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pseudomonas aeruginosa; Signal Transduction | 2007 |
Effect of 14-membered-ring macrolides on production of interleukin-8 mediated by protease-activated receptor 2 in human keratinocytes.
Topics: Cells, Cultured; Clarithromycin; Epidermal Cells; Epidermis; Erythromycin; Humans; Interleukin-1beta; Interleukin-8; Keratinocytes; Macrolides; Receptor, PAR-2; Roxithromycin | 2008 |
Anti-inflammatory effects of garenoxacin on IL-8 production and ERK1/2 activation induced by lipopolysaccharides in A549 and THP-1 cells.
Topics: Ampicillin; Anti-Inflammatory Agents; Cell Line; Clarithromycin; Enzyme Activation; Fluoroquinolones; Humans; Immunologic Factors; Interleukin-8; Ketolides; Lipopolysaccharides; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; RNA, Messenger | 2011 |
[The effects of macrolides (EM900, clarithromycin and azithromycin) on IL-17-induced IL-8 production by airway epithelial cells].
Topics: Anti-Inflammatory Agents; Azithromycin; Cells, Cultured; Clarithromycin; Erythromycin; Humans; Interleukin-17; Interleukin-8; Recombinant Proteins; Respiratory Mucosa | 2009 |
Clarithromycin modulates Helicobacter pylori-induced activation of nuclear factor-κB through classical and alternative pathways in gastric epithelial cells.
Topics: Antigens, Bacterial; Bacterial Proteins; Blotting, Western; Cell Line, Tumor; Chromatography, Liquid; Clarithromycin; Electrophoresis, Gel, Two-Dimensional; Epithelial Cells; Gene Expression Profiling; Helicobacter pylori; Humans; Immunologic Factors; Interleukin-8; NF-kappa B; Proteome; Reverse Transcriptase Polymerase Chain Reaction; Tandem Mass Spectrometry | 2014 |
Macrolides inhibit cytokine production by alveolar macrophages in bronchiolitis obliterans organizing pneumonia.
Topics: Aged; Azithromycin; Cells, Cultured; Chemokines, CC; Clarithromycin; Cryptogenic Organizing Pneumonia; Cytokines; Dexamethasone; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Humans; Interleukin-1beta; Interleukin-6; Interleukin-8; Lipopolysaccharides; Macrophages, Alveolar; Male; Middle Aged; Receptors, Tumor Necrosis Factor, Type II; Tumor Necrosis Factor-alpha | 2013 |
Immunomodulatory effects of a low-dose clarithromycin-based macrolide solution pressurised metered dose inhaler.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cell Line; Chemistry, Pharmaceutical; Clarithromycin; Dose-Response Relationship, Drug; Electric Impedance; Epithelial Cells; Equipment Design; Humans; Immunologic Factors; Interleukin-8; Lung; Metered Dose Inhalers; Mucus; Permeability; Pharmaceutical Solutions; Pressure; Time Factors | 2015 |
Cryptogenic Organizing Pneumonia: IL-1β, IL-6, IL-8, and TGF- β1 Serum Concentrations and Response to Clarithromycin Treatment.
Topics: Aged; Biomarkers; Clarithromycin; Cryptogenic Organizing Pneumonia; Female; Follow-Up Studies; Humans; Interleukin-1beta; Interleukin-6; Interleukin-8; Male; Middle Aged; Prognosis; Protein Synthesis Inhibitors; Transforming Growth Factor beta1 | 2016 |
Long-term treatment of clarithromycin at a low concentration improves hydrogen peroxide-induced oxidant/antioxidant imbalance in human small airway epithelial cells by increasing Nrf2 mRNA expression.
Topics: Antioxidants; Cell Survival; Cells, Cultured; Clarithromycin; Dose-Response Relationship, Drug; Epithelial Cells; Gene Expression; Humans; Hydrogen Peroxide; Interleukin-8; NF-E2-Related Factor 2; Oxidants; Respiratory Mucosa; RNA, Messenger; Time Factors; Treatment Outcome | 2017 |
Clarithromycin decreases rhinovirus replication and cytokine production in nasal epithelial cells from subjects with bronchial asthma: effects on IL-6, IL-8 and IL-33.
Topics: Antiviral Agents; Asthma; Cells, Cultured; Clarithromycin; Cytokines; Epithelial Cells; Female; Humans; Interleukin-33; Interleukin-6; Interleukin-8; Male; Middle Aged; Rhinovirus; Virus Replication | 2020 |
Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice.
Topics: Animals; Bacterial Proteins; Clarithromycin; Cystic Fibrosis; Disease Models, Animal; Female; Humans; Interleukin-8; Lung; Mice; Mice, Inbred C57BL; Mice, Knockout; Pseudomonas aeruginosa; Pseudomonas Infections; Virulence Factors | 2018 |
Anti-Inflammatory Effects of EM900 on Cultured Human Nasal Epithelial Cells.
Topics: Anti-Inflammatory Agents; Cells, Cultured; Clarithromycin; Epithelial Cells; Erythromycin; Humans; Inflammation Mediators; Interleukin-8; Nasal Mucosa; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2018 |
The Mechanism of Action of Nanomaterials Loaded with Clarithromycin after Sinusitis Surgery under the Guidance of Dynamic Enhanced Scanning.
Topics: Clarithromycin; Humans; Interleukin-4; Interleukin-8; Nanoparticle Drug Delivery System; Nanostructures; Sinusitis; Staphylococcus aureus; Tumor Necrosis Factor-alpha | 2022 |